China National Pharmaceutical Group Corporation（Sinopharm）is a centralized enterprise directly managed by the State-owned Assets Supervision and Administration Commission of the State Council（SASAC）with life and health as its main business. It owns 8 tertiary hospitals, 21 secondary and specialized hospitals, 141 medical institutions, with more than 20,000 healthcare workers and 20,000 beds, and has formed a three-dimensional pattern of development of general hospitals and specialized medical institutions with special features, such as stomatology, maternity and child care, medical aesthetics, and blood purification centers. It has formed a three-dimensional pattern of co-development of comprehensive hospitals and specialty medical institutions such as stomatology, maternity and child care,medical cosmetology and blood purification centers. The medical care and recreation segment has undertaken the task of reforming the state's medical care institutions, and has built 58 recreation bases with 15,000 beds in 18 provinces and municipalities across the country, covering the business areas of Beijing, Tianjin, Hebei, Bohai Rim and the rest of the world.

　　 为集团医疗打造立体诊疗格局，驱动业务高质量可持续发展

　　依据国家集团医疗机构相关政策,构建国药医疗集团大数据基座,助力国药医疗集团业务数字化转型、管理数字化,执行集团数据战略。通过相关指标配置自动生成管理报表,助力管理者进行运行状况的总体分析和评价,驱动业务高质量可持续发展。